{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:59:33Z","timestamp":1788285573492,"version":"build-2803163510"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,28]]},"abstract":"<jats:p>\n                    Currently, the precise interplay between autoimmune thyroiditis, particularly Hashimoto thyroiditis, and thyroid cancer remains ambiguous. While certain observational studies suggest autoimmune thyroiditis (including Hashimoto thyroiditis) as a predisposing factor for thyroid cancer. Nevertheless, it is still uncertain whether autoimmune thyroiditis is independently associated with thyroid cancer. We employed Mendelian randomization (MR) study methodology, a genetic analysis approach, to evaluate the causal impact of autoimmune thyroiditis on the occurrence of thyroid cancer. We obtained and synthesized statistical data by utilizing public available genome-wide association studies (GWAS). Our study utilized GWAS summary statistics datasets associated with autoimmune thyroiditis (including Hashimoto thyroiditis) as the exposure data source and selected GWAS summary statistics datasets related to thyroid cancer as the outcome data source. Single nucleotide polymorphisms closely associated with autoimmune thyroiditis were chosen as instrumental variables. We conducted 2-sample MR analyses to elucidate the causal association between autoimmune thyroiditis and thyroid cancer. The inverse variance-weighted (IVW) method was employed as the primary methodology, supplemented by additional MR methods including MR-Egger regression, weighted median, simple mode, and weighted mode analyses, to bolster the robustness of our findings. The MR analysis conducted using the IVW method did not confirm a causal relationship between autoimmune thyroiditis and thyroid cancer (odds ratio [OR]\u2005=\u20050.8554, 95% confidence interval [CI]: 0.7193 to 1.0172,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0772; OR\u2005=\u20050.8477, 95% CI: 0.7159 to 1.0039,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0555; and OR\u2005=\u20051.1324, 95% CI: 0.9342 to 1.3725,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.2052, from 3 eligible dataset analyses, respectively). Additionally, MR analysis did not observe a causal association between Hashimoto thyroiditis and thyroid cancer (OR\u2005=\u20051.0449, 95% CI: 0.9400 to 1.1615,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.4155; and OR\u2005=\u20050.9897, 95% CI: 0.8174 to 1.1984,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.9159, from 2 eligible dataset analyses, respectively). Consistency in results across alternative MR methods was observed. This study employing MR methodology indicates the absence of significant causal relationship between exposure to autoimmune thyroiditis (including Hashimoto thyroiditis) and thyroid cancer. Further validation through larger-scale studies with increased sample sizes is warranted in future investigations.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000041633","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T15:04:09Z","timestamp":1740755049000},"page":"e41633","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of causal association between autoimmune thyroiditis and thyroid cancer: A Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1902-7715","authenticated-orcid":false,"given":"Qihong","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Anorectal Surgery, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiabin","family":"Lan","sequence":"additional","affiliation":[{"name":"Department of Thyroid Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250228","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000516469","article-title":"European thyroid association and cardiovascular and interventional radiological society of Europe 2021 clinical practice guideline for the use of minimally invasive treatments in malignant thyroid lesions.","volume":"10","author":"Mauri","year":"2021","journal-title":"Eur Thyroid J"},{"key":"R2-20250228","article-title":"Surveillance, epidemiology, and end results program. Cancer stat facts: thyroid cancer."},{"key":"R3-20250228","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R4-20250228","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s13193-021-01309-5","article-title":"Prognostic impact of focal poorly differentiated areas in follicular differentiated thyroid cancer: is it a distinct entity from poorly differentiated thyroid cancer?","volume":"13","author":"Panchangam","year":"2022","journal-title":"Indian J Surg Oncol"},{"key":"R5-20250228","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States.","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"R6-20250228","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF03401282","article-title":"Hashimoto\u2019s thyroiditis: history and future outlook.","volume":"12","author":"Hiromatsu","year":"2013","journal-title":"Hormones (Athens)"},{"key":"R7-20250228","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders.","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"R8-20250228","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archsurg.1955.01270080137023","article-title":"Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland.","volume":"70","author":"Dailey","year":"1955","journal-title":"AMA Arch Surg"},{"key":"R9-20250228","first-page":"475","article-title":"Risk genetic polymorphism and haplotype associated with papillary thyroid cancer and their relation to associated diseases in Slovak population.","volume":"123","author":"Duffek","year":"2022","journal-title":"Bratisl Lek Listy"},{"key":"R10-20250228","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/0194599812472426","article-title":"Hashimoto\u2019s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.","volume":"148","author":"Lun","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R11-20250228","doi-asserted-by":"crossref","first-page":"801925","DOI":"10.3389\/fendo.2022.801925","article-title":"Hashimoto\u2019s thyroiditis: a \u201cdouble-edged sword\u201d in thyroid carcinoma.","volume":"13","author":"Xu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R12-20250228","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/ije\/dyu176","article-title":"Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways.","volume":"44","author":"Burgess","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R13-20250228","doi-asserted-by":"crossref","first-page":"a040501","DOI":"10.1101\/cshperspect.a040501","article-title":"Mendelian randomization: concepts and scope.","volume":"12","author":"Richmond","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R14-20250228","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"R15-20250228","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/bimj.201200104","article-title":"Identification of causal effects using instrumental variables in randomized trials with stochastic compliance.","volume":"55","author":"Scosyrev","year":"2013","journal-title":"Biom J"},{"key":"R16-20250228","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"R17-20250228","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/gepi.22295","article-title":"A comparison of robust Mendelian randomization methods using summary data.","volume":"44","author":"Slob","year":"2020","journal-title":"Genet Epidemiol"},{"key":"R18-20250228","doi-asserted-by":"crossref","first-page":"14517","DOI":"10.1038\/ncomms14517","article-title":"A genome-wide association study yields five novel thyroid cancer risk loci.","volume":"8","author":"Gudmundsson","year":"2017","journal-title":"Nat Commun"},{"key":"R20-20250228","first-page":"a041302","article-title":"Mendelian randomization.","volume":"12","author":"Birney","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R21-20250228","doi-asserted-by":"crossref","first-page":"e2783","DOI":"10.1210\/clinem\/dgac196","article-title":"Appraising the effect of potential risk factors on thyroid cancer: a Mendelian randomization study.","volume":"107","author":"Huang","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-20250228","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1093\/bioinformatics\/btw373","article-title":"PhenoScanner: a database of human genotype-phenotype associations.","volume":"32","author":"Staley","year":"2016","journal-title":"Bioinformatics"},{"key":"R23-20250228","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1053\/j.gastro.2021.11.015","article-title":"Integrative analysis of the inflammatory bowel disease serum metabolome improves our understanding of genetic etiology and points to novel putative therapeutic targets.","volume":"162","author":"Di\u2019Narzo","year":"2022","journal-title":"Gastroenterology"},{"key":"R24-20250228","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/CIRCULATIONAHA.121.058389","article-title":"Effects of coronary artery disease-associated variants on vascular smooth muscle cells.","volume":"146","author":"Solomon","year":"2022","journal-title":"Circulation"},{"key":"R25-20250228","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","article-title":"Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.","volume":"52","author":"Zheng","year":"2020","journal-title":"Nat Genet"},{"key":"R26-20250228","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/ijc.29067","article-title":"Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: the EPIC study.","volume":"136","author":"Zamora-Ros","year":"2015","journal-title":"Int J Cancer"},{"key":"R27-20250228","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.3390\/cancers13236038","article-title":"The BRAF(V600E) mutation is not a risk factor for more aggressive tumor behavior in radiogenic and sporadic papillary thyroid carcinoma at a young age.","volume":"13","author":"Zurnadzhy","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R28-20250228","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.3390\/cancers14246172","article-title":"Thyroid carcinoma: a review for 25 years of environmental risk factors studies.","volume":"14","author":"Kruger","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R29-20250228","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1200\/JCO.21.02618","article-title":"Pre-existing thyroid autoimmunity and risk of papillary thyroid cancer: a nested case-control study of US active-duty personnel.","volume":"40","author":"McLeod","year":"2022","journal-title":"J Clin Oncol"},{"key":"R30-20250228","first-page":"885","article-title":"Influence of autoimmune thyroiditis on the prognosis of papillary thyroid carcinoma.","volume":"123","author":"Grigerova","year":"2022","journal-title":"Bratisl Lek Listy"},{"key":"R31-20250228","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","article-title":"Hashimoto thyroiditis: clinical and diagnostic criteria.","volume":"13","author":"Caturegli","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R32-20250228","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/cells12060918","article-title":"Molecular mechanisms in autoimmune thyroid disease.","volume":"12","author":"Vargas-Uricoechea","year":"2023","journal-title":"Cells"},{"key":"R33-20250228","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1055\/a-0856-1044","article-title":"Can supplementation with vitamin D modify thyroid autoantibodies (Anti-TPO Ab, Anti-Tg Ab) and thyroid profile (T3, T4, TSH) in Hashimoto\u2019s thyroiditis? A double blind, randomized clinical trial.","volume":"51","author":"Chahardoli","year":"2019","journal-title":"Horm Metab Res"},{"key":"R34-20250228","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1055\/a-0799-5068","article-title":"Autoimmune thyroid diseases.","volume":"50","author":"Banga","year":"2018","journal-title":"Horm Metab Res"},{"key":"R35-20250228","doi-asserted-by":"crossref","first-page":"e230193","DOI":"10.1530\/ETJ-23-0193","article-title":"Significance of thyroperoxidase and thyroglobulin antibodies in medically treated Graves\u2019 disease.","volume":"12","author":"Constantinescu","year":"2023","journal-title":"Eur Thyroid J"},{"key":"R36-20250228","doi-asserted-by":"crossref","first-page":"102649","DOI":"10.1016\/j.autrev.2020.102649","article-title":"Hashimoto\u2019s thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation.","volume":"19","author":"Ralli","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R37-20250228","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41467-022-28120-2","article-title":"Lymphocyte infiltration and thyrocyte destruction are driven by stromal and immune cell components in Hashimoto\u2019s thyroiditis.","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"key":"R38-20250228","doi-asserted-by":"crossref","first-page":"8263829","DOI":"10.1155\/2021\/8263829","article-title":"Integrative analyses of genes associated with Hashimoto\u2019s thyroiditis.","volume":"2021","author":"Qiu","year":"2021","journal-title":"J Immunol Res"},{"key":"R39-20250228","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1210\/clinem\/dgz225","article-title":"The genetic basis of thyroid function: novel findings and new approaches.","volume":"105","author":"Kus","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R40-20250228","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2015.07.009","article-title":"Immunogenetics of autoimmune thyroid diseases: a comprehensive review.","volume":"64","author":"Lee","year":"2015","journal-title":"J Autoimmun"},{"key":"R41-20250228","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/MED.0b013e3282ef1c48","article-title":"Environmental factors and genetic background that interact to cause autoimmune thyroid disease.","volume":"14","author":"Guarneri","year":"2007","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R42-20250228","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11154-018-9479-7","article-title":"Immunoendocrinology: when (neuro)endocrinology and immunology meet.","volume":"19","author":"Koch","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"key":"R43-20250228","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/thy.2005.15.239","article-title":"Immunoregulatory and susceptibility genes in thyroid and polyglandular autoimmunity.","volume":"15","author":"Dittmar","year":"2005","journal-title":"Thyroid"},{"key":"R44-20250228","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/08830185.2015.1065828","article-title":"Genes and environment as predisposing factors in autoimmunity: acceleration of spontaneous thyroiditis by dietary iodide in NOD.H2(h4) mice.","volume":"34","author":"Kolypetri","year":"2015","journal-title":"Int Rev Immunol"},{"key":"R45-20250228","first-page":"283","article-title":"The role of environmental factors in autoimmune thyroiditis.","volume":"31","author":"Hybenova","year":"2010","journal-title":"Neuro Endocrinol Lett"},{"key":"R46-20250228","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4183\/aeb.2022.74","article-title":"Association between Hashimoto\u2019s thyroiditis and papillary thyroid cancer: a single center experience.","volume":"18","author":"Danis","year":"2022","journal-title":"Acta Endocrinol (Buchar)"},{"key":"R47-20250228","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1210\/jc.2012-2978","article-title":"Clinical Review: Hashimoto\u2019s thyroiditis and papillary thyroid carcinoma: is there a correlation?","volume":"98","author":"Jankovic","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-20250228","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fonc.2017.00053","article-title":"Association between Hashimoto\u2019s thyroiditis and thyroid cancer in 64,628 patients.","volume":"7","author":"Resende de Paiva","year":"2017","journal-title":"Front Oncol"},{"key":"R49-20250228","doi-asserted-by":"crossref","first-page":"62414","DOI":"10.18632\/oncotarget.18620","article-title":"A meta-analysis of Hashimoto\u2019s thyroiditis and papillary thyroid carcinoma risk.","volume":"8","author":"Lai","year":"2017","journal-title":"Oncotarget"},{"key":"R50-20250228","doi-asserted-by":"crossref","first-page":"393","DOI":"10.14639\/0392-100X-1709","article-title":"Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.","volume":"37","author":"Liang","year":"2017","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"R51-20250228","doi-asserted-by":"crossref","first-page":"6757154","DOI":"10.1155\/2016\/6757154","article-title":"Thyroid hormones, oxidative stress, and inflammation.","volume":"2016","author":"Mancini","year":"2016","journal-title":"Mediators Inflamm"},{"key":"R52-20250228","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.3390\/ijms23126456","article-title":"Cross-talk between the cytokine IL-37 and thyroid hormones in modulating chronic inflammation associated with target organ damage in age-related metabolic and vascular conditions.","volume":"23","author":"Majnaric","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R53-20250228","doi-asserted-by":"crossref","first-page":"e0234566","DOI":"10.1371\/journal.pone.0234566","article-title":"Genetic relationship between Hashimoto\u2019s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto\u2019s thyroiditis.","volume":"15","author":"Subhi","year":"2020","journal-title":"PLoS One"},{"key":"R54-20250228","doi-asserted-by":"crossref","first-page":"103948","DOI":"10.1016\/j.cellimm.2019.103948","article-title":"High iodine induces DNA damage in autoimmune thyroiditis partially by inhibiting the DNA repair protein MTH1.","volume":"344","author":"Li","year":"2019","journal-title":"Cell Immunol"},{"key":"R55-20250228","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1055\/s-0043-120922","article-title":"Papillary thyroid cancer and coexisting autoimmune thyroiditis.","volume":"49","author":"Veit","year":"2017","journal-title":"Horm Metab Res"},{"key":"R56-20250228","doi-asserted-by":"crossref","first-page":"959595","DOI":"10.3389\/fonc.2022.959595","article-title":"Association between hashimoto thyroiditis and differentiated thyroid cancer: a single-center experience.","volume":"12","author":"Cappellacci","year":"2022","journal-title":"Front Oncol"},{"key":"R57-20250228","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/s41390-023-02971-x","article-title":"Association of congenital iodine deficiency syndrome and differentiated thyroid cancer: a Mendelian randomization study.","volume":"95","author":"Liang","year":"2024","journal-title":"Pediatr Res"},{"key":"R58-20250228","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.3390\/cancers13143609","article-title":"TNF-alpha may exert different antitumor effects in response to radioactive iodine therapy in papillary thyroid cancer with\/without autoimmune thyroiditis.","volume":"13","author":"Gheorghe","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R59-20250228","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1161\/CIRCULATIONAHA.117.028307","article-title":"Reverse causality in cardiovascular epidemiological research: more common than imagined?","volume":"135","author":"Sattar","year":"2017","journal-title":"Circulation"},{"key":"R60-20250228","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data.","volume":"27","author":"Sekula","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R61-20250228","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R62-20250228","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R63-20250228","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/jamaoto.2021.3077","article-title":"Prevalence and risk factors for multifocality in pediatric thyroid cancer.","volume":"147","author":"Banik","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R64-20250228","doi-asserted-by":"crossref","first-page":"886953","DOI":"10.3389\/fendo.2022.886953","article-title":"Prediction models constructed for Hashimoto\u2019s thyroiditis risk based on clinical and laboratory factors.","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:31:51Z","timestamp":1785850311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041633","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]}}}